Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Purisys logo — Supporting Pharma and Biotech Companies with Commercial CDMO...

Purisys

Supporting Pharma and Biotech Companies with Commercial CDMO Services, Reference Standards and Controlled Substance APIs

Founded 2019 United States Athens, United States 28 employees Information Technology, Manufacturing

General Information

Company Name Purisys
Founded Year 2019
Location United States Athens, United States +1
Employees 28
Industries Information Technology, Manufacturing
Social

Get notified when Purisys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Purisys

Purisys is a global leader in the custom synthesis of active pharmaceutical ingredients, offering support to pharma and biotech companies with APIs, reference standards, controlled substances, cannabinoids, psychedelics, and cGMP clinical and niche commercial CDMO services. Established in 2019 as a spin-off from Noramco, Purisys traces its manufacturing roots back to 1979 as part of Johnson & Johnson. The company is renowned for producing over 50 major and minor cannabinoids, along with degradants, metabolites, and analytical standards, thereby addressing the evolving needs of the industry. Notably, they hold DEA licenses for several psychedelic basic classes and have successfully manufactured GMP psilocybin and Psilocin to support customers’ R&D programs. Purisys stands out for providing comprehensive development, analytical, and manufacturing services from preclinical to commercial APIs for pharmaceutical and biotech clients. Their capabilities extend to difficult-to-manufacture APIs, including controlled substances, injectable-grade APIs, HPAPIs, and environmentally sensitive APIs. The company's stock of 250+ reference standards with structural elucidation and comprehensive analytical data is distributed to 30+ countries across 6 continents. Their capabilities also include excipient compatibility, formulation, solid state, cGMP manufacturing, HPAPI, and labile molecule development, and method development. Overall, Purisys offers a wide range of services and products that cater to the needs of the pharmaceutical and biotech industries, positioning itself as a key player in the global pharmaceutical and biotech landscape.

Taxonomy: Pharmaceutical APIs, CDMO Services, Cannabinoids, Psychedelics, Reference Standards, Controlled Substances, Custom Synthesis, Analytical Chemistry, Process Chemistry, FDA-inspected GMP Manufacturing, Orphan Drug Development, High Potency APIs (HPAPI), Structure Elucidation, Bio/Pharma CDMO, Clinical Synthesis

No funding data available for Purisys yet.

Get notified when Purisys raises funding

FAQ About Purisys

Supporting Pharma and Biotech Companies with Commercial CDMO Services, Reference Standards and Controlled Substance APIs
Purisys was founded in 2019.
Purisys is headquartered in Athens, United States.
Purisys operates in the following industries: Information Technology, Manufacturing.
Purisys has approximately 28 employees.

We're actively collecting intelligence on Purisys.

Track Purisys to get notified

Don't just browse. Track.

Signal Tracker monitors Purisys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy